Characterization of the Nutritional Status in the Patient With Liver Cirrhosis

Puerta de Hierro University Hospital32 enrolled

Overview

In the subgroup of patients with sarcopenia, regardless of their body mass index, we want to verify the real impact of nutritional supplements with branched chain amino acids on the standard treatment based on nutritional intervention and physical exercise.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Sarcopenia

Interventions

Branched chain amino acids (BRCA)DIETARY_SUPPLEMENT

They were with BRCA during the day apart of following the standard recommendations

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Cirrhotic patients with sarcopenia in abdominal CT. Exclusion Criteria: * chronic renal failure or being on hemodialysis * active hepatitis B or C virus infection * active alcohol abuse * coinfection with human immunodeficiency virus * renal or previous liver transplantation * history of neoplasia requiring chemotherapy or radiotherapy * hepatocellular carcinoma outside of Milan criteria * TIPs * unwillingness to participate in the study.

Locations (1)

Jose Luis Calleja

Majadahonda, Madrid, Spain

Outcomes

Primary Outcomes

Change of muscle mass in patients with sarcopenia

To assess whether to add to dietary and physical activity recommendations, nutritional supplements with BRCA under usual clinical conditions can lead to a greater change of muscle mass in patients with sarcopenia

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.